Rouphael, N. G., Branche, A. R., Diemert, D. J., Falsey, A. R., Losada, C., Baden, L. R., … Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team. (2023). Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial. J Infect Dis, 228(12), 1662–1666. https://doi.org/10.1093/infdis/jiad323

Rouphael, Nadine G., Angela R. Branche, David J. Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden, Sharon E. Frey, et al. “Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.” J Infect Dis 228, no. 12 (December 20, 2023): 1662–66. https://doi.org/10.1093/infdis/jiad323.

Rouphael NG, Branche AR, Diemert DJ, Falsey AR, Losada C, Baden LR, et al. Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial. J Infect Dis. 2023 Dec 20;228(12):1662–6.

Rouphael, Nadine G., et al. “Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.” J Infect Dis, vol. 228, no. 12, Dec. 2023, pp. 1662–66. Pubmed, doi:10.1093/infdis/jiad323.

Rouphael NG, Branche AR, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bäcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Netzl A, Smith DJ, Telu K, Mu J, McQuarrie LJ, Makowski M, Makhene MK, Crandon S, Montefiori DC, Roberts PC, Beigel JH, Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team. Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial. J Infect Dis. 2023 Dec 20;228(12):1662–1666.